Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 53,681 | 256,492 | 206,838 | 160,296 | 68,070 |
| Depreciation Amortization | 26,813 | 98,597 | 74,022 | 49,624 | 25,197 |
| Income taxes - deferred | 16 | 4,988 | -9,146 | -3,741 | -7,307 |
| Accounts receivable | -82,956 | -18,463 | 15,234 | -420 | -24,647 |
| Other Working Capital | -56,548 | -17,012 | -4,838 | 20,640 | -16,261 |
| Other Operating Activity | 113,793 | 147,596 | 67,257 | 55,277 | 61,727 |
| Operating Cash Flow | $54,799 | $472,198 | $349,367 | $281,676 | $106,779 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 15,911 | 15,911 | 15,911 | N/A |
| PPE Investments | -4,628 | -36,348 | -20,104 | -13,676 | -6,779 |
| Net Acquisitions | N/A | -1,362 | -1,362 | -1,362 | -1,362 |
| Purchase Of Investment | N/A | -75 | N/A | N/A | N/A |
| Purchase Sale Intangibles | 5,873 | -5,593 | N/A | N/A | N/A |
| Other Investing Activity | 5,873 | 11,288 | 16,881 | 16,881 | 0 |
| Investing Cash Flow | $1,245 | $-10,586 | $11,326 | $17,754 | $-8,141 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,253 | 43,697 | 38,681 | 26,124 | 22,157 |
| Common Stock Repurchased | -70,005 | -125,253 | -90,251 | -50,260 | -15,000 |
| Dividend Paid | -34,339 | -126,599 | -95,010 | -63,377 | -31,548 |
| Other Financing Activity | -31,743 | -39,083 | -36,603 | -34,931 | -33,180 |
| Financing Cash Flow | $-121,834 | $-247,238 | $-183,183 | $-122,444 | $-57,571 |
| Exchange Rate Effect | -5 | 1,235 | 1,302 | -4,396 | -7,162 |
| Beginning Cash Position | 793,361 | 577,752 | 577,752 | 577,752 | 577,752 |
| End Cash Position | 727,566 | 793,361 | 756,564 | 750,342 | 611,657 |
| Net Cash Flow | $-65,795 | $215,609 | $178,812 | $172,590 | $33,905 |
| Free Cash Flow | |||||
| Operating Cash Flow | 54,799 | 472,198 | 349,367 | 281,676 | 106,779 |
| Capital Expenditure | -4,628 | -36,348 | -20,104 | -13,676 | -6,779 |
| Free Cash Flow | 50,171 | 435,850 | 329,263 | 268,000 | 100,000 |